77 results
Page 2 of 4
8-K
EX-99.1
zs9 sgqec
11 May 23
NeuroOne® Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
4:16pm
8-K
EX-99.1
p0luj7vev2hyd09pgr
22 Dec 22
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2022 Financial Results
9:11am
424B5
0spdhfonlwfkg 9s
22 Dec 22
Prospectus supplement for primary offering
6:43am
8-K
EX-99.1
5dzc3
25 Oct 22
NeuroOne® Receives FDA 510(k) Clearance to Market its Evo® sEEG System for Less than 30 Day Use
9:19am
8-K
EX-99.1
vimx4fn30mzhw1gl53iw
14 Sep 22
Regulation FD Disclosure
8:30am
8-K
EX-99.1
xmwm fg4b4s
11 Aug 22
NeuroOne® Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
4:49pm
8-K
EX-99.1
fe9aalwzzs 3lvm
3 Aug 22
NeuroOne® Announces $3.5 Million Accelerated Milestone Payment from Zimmer Biomet for Evo® sEEG Electrode
9:34am
8-K
EX-99.1
uibb3h1
2 Jun 22
NeuroOne® Issues Letter to Stockholders in Connection With 2022 Annual Meeting of Stockholders
4:05pm
8-K
EX-99.1
w11ybs2 jyzaxd
16 May 22
NeuroOne Provides Evo® sEEG Update
4:38pm
8-K
EX-99.1
pdgq4shru
12 May 22
NeuroOne Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
4:17pm
8-K
EX-99.1
qu9ic t31
14 Feb 22
NeuroOne Reports First Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-99.1
peuh3dd
15 Dec 21
NeuroOne Reports Fourth Fiscal Quarter and Full Fiscal Year 2021
8:15am